Table 1.
Summary of the 18 Articles Identified Through the Systematic Review.
Study No. | First Author (Year of Publication) | N | Male | Female | Age in Years, Mean (Range) | Lesion Size (cm2) Mean (Range) | Level of Evidence | Level of Evidence, Study Methodology | Scaffolding Adjuvant | Injectable Adjuvant | Microfracture Only Cohort | IKDC | VAS Pain | Lysholm | Cincinnati | WOMAC | Tegner | KOOS |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Becher et al. (2015)33 | 5 | 3 | 2 | 27.6 (15-40) | 4.0 (3.0-5.0) | Level IV | Case series | ✓ | ✓ | ||||||||
2 | Enea et al. (2015)28 | 9 | 5 | 4 | 51.0 (28-70) | 3.5 (1.8-9.0) | Level IV | Case series | ✓ | ✓ | ✓ | ✓ | ✓ | |||||
3 | Koh et al. (2016)13 | 80 | 30 | 50 | 38.7 (18-50) | 4.7 | Level II | Randomized controlled trial | ✓ | ✓ | ✓ | ✓ | ✓ | |||||
4 | Shive et al. (2015)24 | 80 | 48 | 32 | 36.1 (18-55) | 2.1 | Level I | Randomized controlled trial | ✓ | ✓ | ✓ | |||||||
5a | Siclari et al. (2014)34 | 52 | 20 | 32 | 44.0 (31-65) | 2.7 (1.5-5.0) | Level IV | Case series | ✓ | ✓ | ||||||||
6 | Anders et al. (2013)22 | 38 | 31 | 7 | 37.1 (21-50) | 3.4 (2.1-6.6) | Level II | Randomized controlled trial | ✓ | ✓ | ✓ | |||||||
7 | Chung et al. (2013)29 | 36 | 16 | 20 | 46.3 | 1.4 | Level II | Randomized controlled trial | ✓ | ✓ | ✓ | ✓ | ||||||
8 | Enea et al. (2013)30 | 9 | 5 | 4 | 48 | 2.6 | Level IV | Case series | ✓ | ✓ | ✓ | ✓ | ✓ | |||||
9 | Gille et al. (2013)22 | 57 | 38 | 19 | 37.3 (17-61) | 3.4 (1.0-9.0) | Level IV | Case series | ✓ | ✓ | ✓ | ✓ | ||||||
10 | Saw et al. (2013)35 | 49 | 17 | 32 | 39.9 (22-50) | Not stated | Level II | Randomized controlled trialb | ✓ | ✓ | ✓ | |||||||
11 | Siclari et al. (2013)16 | 52 | 20 | 32 | 44.0 (31-65) | 2.7 (1.5-5.0) | Level IV | Case series | ✓ | |||||||||
12 | Lee et al. (2012)15 | 49 | 29 | 20 | 46 (41-48) | <4 | Level II | Randomized controlled trial | ✓ | ✓ | ✓ | ✓ | ✓ | |||||
13 | Lee et al. (2012)14 | 70 | 36 | 34 | <55 | N/A | Level II | Randomized controlled trialb | ✓ | ✓ | ✓ | ✓ | ||||||
14a | Siclari et al. (2012)36 | 52 | 20 | 32 | 44.0 (31-65) | 2.7 (1.5-5.0) | Level IV | Case series | ✓ | ✓ | ||||||||
15 | Dhollander et al. (2011)31 | 5 | 2 | 3 | 29.8 (16-39) | 2.5 (1.5-5.0) | Level IV | Case series | ✓ | ✓ | ✓ | |||||||
16 | Kusano et al. (2011)23 | 40 | 23 | 17 | 45.3 | 3.9 | Level IV | Case series | ✓ | ✓ | ✓ | ✓ | ||||||
17 | Gille et al. (2010)32 | 27 | 16 | 11 | 39 (16-50) | 4.2 (1.3-8.8) | Level IV | Case series | ✓ | ✓ | ✓ | |||||||
18 | Pascarella et al. (2009)20 | 19 | 12 | 7 | 26 (18-50) | 3.6 (2.8-3.9) | Level IV | Case series | ✓ | ✓ | ✓ |
IKDC = International Knee Documentation Committee Subjective Knee Form; KOOS = Knee injury and Osteoarthritis Outcome Score; N/A = not applicable; VAS = visual analog scale; WOMAC = Western Ontario and McMaster Universities Osteoarthritis Index.
Denotes case series following the same group of enrolled patients with outcomes described in three separate publications.
Randomized trial compares 2 different microfracture plus adjuvant interventions.